[Editor's commentary: Clinical use of somatostatin].
Semmelweis Egyetem, Általános Orvostudományi Kar II. Belgyógyászati Klinika Budapest Szentkirályi u. 46. 1088.
Zsolt
Z
Tulassay
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology* / Q000627:therapeutic use; D004067:Digestive System Neoplasms / Q000188:drug therapy / Q000378:metabolism; D005765:Gastrointestinal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D013007:Growth Hormone-Releasing Hormone / Q000037:antagonists & inhibitors*; D006801:Humans; D015282:Octreotide / Q000494:pharmacology* / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000378:metabolism; D013004:Somatostatin / Q000031:analogs & derivatives / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology*
D018931:Antineoplastic Agents, Hormonal; D005765:Gastrointestinal Agents; D013004:Somatostatin; D013007:Growth Hormone-Releasing Hormone; D015282:Octreotide